Page URL:

Mapping the epigenome: Europe leads the way

3 October 2011
Appeared in BioNews 627

The European Commission (EC) is investing €30 million in BLUEPRINT, a project to map the human epigenome - the sum total of the non-coding, but inherited, modifications to DNA.

The work will add 100 or more high-resolution reference epigenome maps for the International Human Epigenome Consortium, putting towards its 2020 target of 1000 reference epigenomes.

The epigenome includes DNA methylation, nucleosome occupancy, histone deacetylation and other histone modifications, and corresponding coding and non-coding RNA. Most of these changes occur in early development, but cells collect further changes throughout their life, some of which can lead to cancer. This means that the epigenome varies from individual to individual, and even from cell to cell, and studying the epigenome could help clarify the links between genes, environment and health or disease.

Initially, the 41 universities, research institutes and industry entrepreneurs, that make up BLUEPRINT will look at the epigenome of 60 different cell types from healthy blood, and 60 blood cancer cell types. Samples will come from the Cambridge BioResource, a panel of volunteers, as well as the International Cancer Genome Consortium and the British Diabetic Twin Study.

The teams will sequence the genome, as well as analyse the pattern of distribution of nine epigenetic markers, with an aim to understand how genes are activated or suppressed. They will also produce low-resolution epigenomic maps from blood samples from 100 healthy people, with support from the Wellcome Trust Sanger Institute.

The focus on blood is partly for ease of access, as blood samples are easily available from biobanks, but also because blood includes cells of different ages and at different stages of development, so that mapping the epigenome may shed some light on how cells develop, and how the epigenome changes in response to the environment.

Launched on 1 October 2011 with a two day meeting at the Royal Netherlands Academy of Arts and Sciences in Amsterdam, BLUEPRINT will be the largest ever project from the EC's health division, with an overall budget of around €40 million. It will run for four and half years and will be led by Professor Henk Stunnenberg of the Nijmegen Centre for Molecular Life Sciences in the Netherlands.

Blueprint for success in human epigenomics?
PHG Foundation |  29 October 2011
Europe Pours $41 Million Into Epigenome
The Scientist |  29 October 2011
Europe to map the human epigenome
Nature News |  28 September 2011
International Human Epigenome Consortium
IHEC |  21 May 2022
23 February 2015 - by Dr Meghna Kataria 
Scientists have unveiled a map of the human epigenome - the suite of molecular controllers which turn genes on and off in every human cell...
8 May 2012 - by Sarah Norcross and Sandy Starr 
The conference 'Genomics in Society: Facts, Fictions and Cultures' marked the 10th anniversary of the Economic and Social Research Council's Genomics Network, and also the passing of nearly ten years since the completion of the Human Genome Project...
10 October 2011 - by Oliver Timmis 
The Faroe Islands is set to become the first region to sequence the genome of its entire population....
20 December 2010 - by Dr Carolina Gemma and Dr Vardhman Rakyan 
In recent years, significant progress has been made in identifying some of the genetic factors that underlie common complex diseases such as diabetes, obesity, hypertension and cancer. This has been possible due to the genome-wide association study (GWAS) approach that involves comparing genetic variants in large numbers of individuals that have the disease versus those that do not...
15 February 2010 - by Charlie McDermott 
The International Human Epigenome Consortium (IHEC), launched in Paris last week, plans to map 1,000 reference epigenomes within a decade...
7 December 2009 - by Dr Aarathi Prasad 
Session 3 of the Progress Educational Trust's annual conference (PET), held on Wednesday 18 November 2009 at Clifford Chance, was chaired by Professor Dian Donnai,Professor of Medical Genetics at the University of Manchester, and started with a talk by Karen Temple, Professor of Medical Genetics and Honorary Consultant in Clinical Genetics at the University of Southampton and Wessex Clinical Genetics Service. Professor Temple gave an intriguing talk on the influence of parent...
19 October 2009 - by Dr Will Fletcher 
The first detailed map of the human epigenome has been published. The epigenome, sometimes described as the 'instruction manual' to the human genome, is a regulatory network of chemical switches that governs the activation of human genes, and is therefore ultimately responsible for how a person grows and develops. Scientists believe that this exciting work could lead to new treatments for a range of illnesses including mental conditions such as schizophrenia
20 July 2009 - by Sandy Starr 
From our perspective at the Progress Educational Trust (PET), one of the most welcome aspects of the House of Lords Science and Technology Committee's new report 'Genomic Medicine' is its consideration of public engagement issues. This section of the report appears to anticipate and complement PET's plans for its 2009 annual conference, entitled 'Does Genetics Matter? Help, Hype and the New Horizon of Epigenetics', which will take place in East London on Wednesday 18 November....
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions

Syndicate this story - click here to enquire about using this story.